IC

Ikarian Capital Portfolio holdings

AUM $302M
1-Year Est. Return 65.21%
This Quarter Est. Return
1 Year Est. Return
+65.21%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$349M
AUM Growth
-$87.3M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
198
New
Increased
Reduced
Closed

Top Buys

1
+$17.1M
2
+$8.3M
3
+$6.55M
4
CLDX icon
Celldex Therapeutics
CLDX
+$5.75M
5
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$5.39M

Top Sells

1
+$11.5M
2
+$7.89M
3
+$6.85M
4
ACAD icon
Acadia Pharmaceuticals
ACAD
+$6.66M
5
XENE icon
Xenon Pharmaceuticals
XENE
+$6.2M

Sector Composition

1 Healthcare 97.45%
2 Consumer Staples 0.57%
3 Technology 0.57%
4 Financials 0.21%
5 Real Estate 0.11%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
151
– –
-31,526
152
– –
-347,545
153
– –
-40,961
154
– –
0
155
– –
0
156
– –
0
157
– –
-196,400
158
– –
0
159
– –
0
160
– –
-229,202
161
– –
-30,727
162
– –
-27,968
163
– –
-44,857
164
– –
0
165
– –
0
166
– –
-83,046
167
– –
-59,422
168
– –
0
169
– –
0
170
– –
0
171
– –
-197,173
172
– –
0
173
– –
-20,160
174
– –
0
175
– –
0
4 5 6
7
8